Mutations in Exon 11 of c-Kit Occur Preferentially in Malignant versus Benign Gastrointestinal Stromal Tumors and Do Not Occur in Leiomyomas or Leiomyosarcomas

1999/01/01 by Jerzy Lasota, Marek Jasinski, Marek Jasiński +3 · 30 citations
Medicine · Immunology and Microbiology · #Gastrointestinal Tumor Research and Treatment #Platelet Disorders and Treatments #Mast cells and histamine

paper · doi:10.1016/s0002-9440(10)65250-9

Cited by

• KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal Tumors
• The Complexity of KIT Gene Mutations and Chromosome Rearrangements and Their Clinical Correlation in Gastrointestinal Stromal (Pacemaker Cell) Tumors
• Gastrointestinal stromal tumors: Recent advances in understanding of their biology
• Immunohistochemical Spectrum of GISTs at Different Sites and Their Differential Diagnosis with a Reference to CD117 (KIT)
• Gastrointestinal Stromal Tumors, Intramural Leiomyomas, and Leiomyosarcomas in the Rectum and Anus
• Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases. [europepmc]
• Frequent occurrence of low grade cases among metastatic gastrointestinal stromal tumours. [europepmc]
• Evaluation of the kinase domain of c-KIT in canine cutaneous mast cell tumors. [europepmc]
• Improved detection of KIT exon 11 duplications in formalin-fixed, paraffin-embedded gastrointestinal stromal tumors. [europepmc]
• Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland. [europepmc]
• Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type. [europepmc]
• The role of mutational analysis of KIT and PDGFRA in gastrointestinal stromal tumors in a clinical setting. [europepmc]
• Analysis of Somatic Mutations in Cancer: Molecular Mechanisms of Activation in the ErbB Family of Receptor Tyrosine Kinases. [europepmc]
• Extended adjuvant therapy with imatinib in patients with gastrointestinal stromal tumors : recommendations for patient selection, risk assessment, and molecular response monitoring. [europepmc]
• The GIST of targeted therapy for malignant melanoma. [europepmc]
• Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumors: a meta-analysis. [europepmc]
• Analysis of mutation of the c-Kit gene and PDGFRA in gastrointestinal stromal tumors. [europepmc]
• PDGFRA and KIT Mutation Status and Its Association With Clinicopathological Properties, Including DOG1. [europepmc]
• Intestinal gastrointestinal stromal tumor in a cat. [europepmc]
• Primary malignant melanoma of esophagus: clinicopathologic characterization of 20 cases including molecular genetic profiling of 15 tumors. [europepmc]
• Clinical Diagnosis of Gastrointestinal Stromal Tumor (GIST): From the Molecular Genetic Point of View. [europepmc]
• Mutational spectrum and classification of novel mutations in patients with metastatic gastrointestinal stromal tumours. [europepmc]
• Persistent Human KIT Receptor Signaling Disposes Murine Placenta to Premature Differentiation Resulting in Severely Disrupted Placental Structure and Functionality. [europepmc]
• Mutation analysis of gastrointestinal stromal tumors using RNA obtained via endoscopic ultrasound-guided fine-needle aspiration. [europepmc]
• Low ETV1 mRNA expression is associated with recurrence in gastrointestinal stromal tumors. [europepmc]
• APC loss induces Warburg effect via increased PKM2 transcription in colorectal cancer. [europepmc]
• Gastrointestinal Stromal Tumors-A Mini Review. [europepmc]
• Molecular Tailored Therapeutic Options for Advanced Gastrointestinal Stromal Tumors (GISTs): Current Practice and Future Perspectives. [europepmc]
• Small Molecule c-KIT Inhibitors for the Treatment of Gastrointestinal Stromal Tumors: A Review on Synthesis, Design Strategies, and Structure-Activity Relationship (SAR). [europepmc]
• An update on gastrointestinal stromal tumors (GISTs) with a focus on extragastrointestinal stromal tumors (EGISTs). [europepmc]